Nicotine reduces effectiveness of Gemcitabine
Added: Tuesday 27 November 2012
A study carried out on mice and in-vitro cells finds that nicotine has an inhibitory effect on the chemotherapy drug Gemcitabine. The experiment suggests that this could have a negative impact on treatment outcomes for patients who smoke. The researchers believe that clinical trials in actual cancer patients are now warranted.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: